149 related articles for article (PubMed ID: 11338664)
1. Substituted phenoxyalkylpiperazines as dopamine D3 receptor ligands.
Laszlovszky I; Acs T; Kiss B; Domány G
Pharmazie; 2001 Apr; 56(4):287-9. PubMed ID: 11338664
[TBL] [Abstract][Full Text] [Related]
2. New substituted 2-methylthiomethyl- and 2-methylsulphinylmethylenebenzimidazoles with D2/5-HT1A activity.
Kostić-Rajacić S; Soskić V; Joksimović J
Pharmazie; 1998 Jul; 53(7):438-41. PubMed ID: 9699220
[TBL] [Abstract][Full Text] [Related]
3. Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines.
Roglić G; Dukić-Stefanović S; Andrić D; Kostić-Rajacić S; Soskić V
Pharmazie; 2001 Oct; 56(10):803-7. PubMed ID: 11683128
[TBL] [Abstract][Full Text] [Related]
4. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
[TBL] [Abstract][Full Text] [Related]
5. Orally active benzamide antipsychotic agents with affinity for dopamine D2, serotonin 5-HT1A, and adrenergic alpha1 receptors.
Reitz AB; Baxter EW; Codd EE; Davis CB; Jordan AD; Maryanoff BE; Maryanoff CA; McDonnell ME; Powell ET; Renzi MJ; Schott MR; Scott MK; Shank RP; Vaught JL
J Med Chem; 1998 Jun; 41(12):1997-2009. PubMed ID: 9622541
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands.
Chu W; Tu Z; McElveen E; Xu J; Taylor M; Luedtke RR; Mach RH
Bioorg Med Chem; 2005 Jan; 13(1):77-87. PubMed ID: 15582454
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1A and D-2 receptor affinity of o-methoxyphenylpiperazine derivatives with terminal benzamide fragment on N-4 alkyl chain. 2.
Perrone R; Berardi F; Leopoldo M; Tortorella V; Lograno MD; Daniele E; Govoni S
Farmaco; 1995; 50(7-8):505-10. PubMed ID: 7669188
[TBL] [Abstract][Full Text] [Related]
8. Novel benzothiazolin-2-one and benzoxazin-3-one arylpiperazine derivatives with mixed 5HT1A/D2 affinity as potential atypical antipsychotics.
Taverne T; Diouf O; Depreux P; Poupaert JH; Lesieur D; Guardiola-Lemaître B; Renard P; Rettori MC; Caignard DH; Pfeiffer B
J Med Chem; 1998 Jun; 41(12):2010-8. PubMed ID: 9622542
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs.
Sukalović V; Andrić D; Roglić G; Kostić-Rajacić S; Schrattenholz A; Soskić V
Eur J Med Chem; 2005 May; 40(5):481-93. PubMed ID: 15893022
[TBL] [Abstract][Full Text] [Related]
10. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
Paluchowska MH; Mokrosz MJ; Charakchieva-Minol S; Duszyńska B; Kozioł A; Wesołowska A; Stachowicz K; Chojnacka-Wójcik E
Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
[TBL] [Abstract][Full Text] [Related]
11. 2-[4-[3-(4-aryl/heteroaryl-1-piperazinyl)propoxy]phenyl]-2H- benzotriazoles and their N-oxides as ligands for serotonin and dopamine receptors.
Sparatore A; Goegan M; Cagnotto A; Sparatore F
Farmaco; 1999 Jun; 54(6):402-10. PubMed ID: 10443019
[TBL] [Abstract][Full Text] [Related]
12. Further SAR study on 11-O-substituted aporphine analogues: identification of highly potent dopamine D3 receptor ligands.
Ye N; Wu Q; Zhu L; Zheng L; Gao B; Zhen X; Zhang A
Bioorg Med Chem; 2011 Mar; 19(6):1999-2008. PubMed ID: 21334902
[TBL] [Abstract][Full Text] [Related]
13. Effect of the amide fragment on 5-HT1A receptor activity of some analogs of MP 3022.
Paluchowska MH; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A
Pol J Pharmacol; 1999; 51(5):415-21. PubMed ID: 10817542
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and affinities for dopamine (D2) and 5-hydroxytryptamine (5-HT2A) receptors of 1-(benzoylpropyl)-4-(1-oxocycloalkyl-2-ethyl)-piperazines as cyclic butyrophenone derivatives.
Raviña E; Fueyo J; Masaguer CF; Negreira J; Cid J; Loza I; Honrubia A; Tristán H; G-Ferreiro T; Fontenla JA; Rosa E; Calleja JM; De Ceballos ML
Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):534-41. PubMed ID: 8882450
[TBL] [Abstract][Full Text] [Related]
17. Structure-affinity relationship studies on D-2/5-HT1A receptor ligands. 4-(2-Heteroarylethyl)-1-arylpiperazines.
Dukić S; Vujović M; Soskić V; Joksimović J
Arzneimittelforschung; 1997 Mar; 47(3):239-43. PubMed ID: 9105540
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 1,4-disubstituted 2-methylpiperazine derivatives, new 5-HT(1A) receptor ligands.
Cybulski M; Dankiewicz W; Chilmończyk Z
Acta Pol Pharm; 2001; 58(5):357-65. PubMed ID: 11876443
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of several substituted phenylpiperazines behaving as mixed D2/5HT1A ligands.
Dukić S; Kostić-Rajacić S; Dragović D; Soskić V; Joksimović J
J Pharm Pharmacol; 1997 Oct; 49(10):1036-41. PubMed ID: 9364416
[TBL] [Abstract][Full Text] [Related]
20. 1,2,3,4-tetrahydroisoquinoline derivatives; lipophilicity evaluation vs. 5-HT1A receptor affinity.
Bojarski AJ; Mokrosz MJ
Pharmazie; 1999 Nov; 54(11):828-30. PubMed ID: 10603608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
